NCT02332642View on ClinicalTrials.gov

Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Immuno-monitoring
Interventions
OTHER

Immuno-monitoring

Trial Locations (1)

68167

Universitätsmedizin Mannheim, Klinik für Dermatologie, Venerologie und Allergologie, Mannheim

All Listed Sponsors
lead

Universitätsmedizin Mannheim

OTHER

NCT02332642 - Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy | Biotech Hunter | Biotech Hunter